Congenital phlebectasia
ICD-10 Q27.4 is a billable code used to indicate a diagnosis of congenital phlebectasia.
Congenital phlebectasia refers to a localized dilation of a vein that is present at birth. This condition can occur in various veins throughout the body, but it is most commonly observed in the lower extremities. The etiology of congenital phlebectasia is often linked to developmental anomalies in the venous system, leading to abnormal venous wall structure and function. Clinically, patients may present with swelling, discomfort, or cosmetic concerns, particularly if the affected vein is prominent. While congenital phlebectasia is generally considered a benign condition, it can sometimes be associated with other congenital malformations, particularly those affecting the circulatory system, such as congenital heart defects. Accurate diagnosis typically involves imaging studies, such as ultrasound or MRI, to assess the extent of the dilation and to rule out associated vascular anomalies. Management may vary from observation to surgical intervention, depending on the severity of symptoms and the impact on the patient's quality of life.
Detailed clinical notes including symptoms, physical examination findings, and any imaging results.
Pediatric patients presenting with limb swelling or cosmetic concerns related to venous dilation.
Consideration of growth and development in pediatric patients, as well as potential psychosocial impacts.
Genetic evaluation reports, family history, and any chromosomal analysis results.
Patients with congenital phlebectasia who also present with other genetic syndromes or chromosomal abnormalities.
Understanding the genetic basis of associated congenital conditions and their implications for family counseling.
Used in cases where congenital phlebectasia leads to significant symptoms requiring intervention.
Document the indication for the procedure and any imaging studies performed.
Consider the pediatric population's unique needs and potential complications.
The primary concern with congenital phlebectasia is the potential for associated complications, such as thrombosis or cosmetic issues, which may require intervention. Accurate coding and documentation are essential to ensure appropriate management and follow-up.
